No | Gender/age | Symptoms | Preoperative chemotherapy | Surgical approach | Ascites (ml) | PCI/CC (Score) | Postoperative chemotherapy | Follow-up (Month) | Survival Status |
---|---|---|---|---|---|---|---|---|---|
1 | Male/33 | Altered bowel habits, abdominal distension and pain | AI solution × 2 cycles | CRS+HIPEC CRS: hepatic round ligament, greater omentum, lesser omentum, abdominal wall tumors, sub mesenteric vein root tumors, transverse colon tumors, left popliteal tumors, ascending colon surface tumors, transverse colon bowel lip, rectum + sigmoid colon, partial ileum + colon HIPEC: doxorubicin 40 mg + ifosfamide 3 g, 43 °C, 60 min | 200 | 30/3 | None | 8.4 | Live |
2 | Male/41 | Stomachache, abdominal distension and pain | None | CRS+HIPEC; CRS: right colon, omentum; HIPEC: cisplatin 120 mg + docetaxel 120 mg, 43 °C, 90 min | None | 7/0 | ICE × 8 cycles | 20.0 | Live |
3 | Male/24 | Abdominal distension, right lower quadrant pain, altered bowel habits | VAC × 4 cycles, IE × 3 cycles, irinotecan + recombinant human endostatin + anlotinib × 10 cycles | CRS+HIPEC CRS: greater omentum, right diaphragm, hepatic hilum tumor, right lobe tumor, rectum + pelvic tumor, mesenteric tumor HIPEC: doxorubicin 120 mg + ifosfamide 3 g, 43 °C, 60 min | 1000 | 24/1 | AIM plan + PD1 (details unknown) | 20.3 | Live |
4 | Male/29 | Abdominal pain and distension, constipation | TC plan × 1 cycle AI solution × 2 cycles | CRS+HIPEC CRS: tumors of the upper abdominal wall, tumors of the left lower abdomen, colonic spleen flexure peritoneum, omental tumors, descending colon peritoneal tumors, hepatic ligament HIPEC: docetaxel 120 mg + ifosfamide 3 g, 43 °C, 60 min | 2200 | 39/3 | AI × 6 cycles IE × 6 cycles | 14.4 | Dead |
5 | Male/27 | Abdominal pain and distension, constipation | AI Plan×7 cycles | CRS+HIPEC CRS: hepatic round ligament, greater omentum, rectal pelvic floor tumor, liver and kidney crypt tumor, small intestinal mesenteric tumor, colon mesenteric tumor, right diaphragm muscle tumor, ileocecal + appendix, left diaphragm muscle tumor HIPEC: docetaxel 120 mg + ifosfamide 3 g, 43 °C, 60 min | 100 | 25/1 | AI solution × 6 cycles + Retroperitoneal lymph node radiotherapy | 28.5 | Dead |
6 | Male/45 | Abdominal pain and distension, exhaustion, fever | None | Laparotomy: partial abdominal tumor resection | Unknown | 38/2 | Unknown | 22.6 | Live |
7 | Male/26 | Abdominal distension with nausea and vomiting | None | CRS+HIPEC CRS: omental tumor, liver curvature tumor, splenic curvature tumor HIPEC: docetaxel 120 mg, 43 °C, 30 min | 1900 | 39/2 | Unknown | 8.9 | Dead |
8 | Male/ 31 | Abdominal pain and distension | IE×1cycles | Laparotomy: partial abdominal tumor resection | None | 31/2 | VAC solution × 5 cycles | 7.5 | Live |